What Researchers Did
Researchers reported a case of methemoglobinemia successfully treated with hyperbaric oxygenation (HBO) monotherapy.
What They Found
They found that a 41-year-old man presenting with severe methemoglobinemia (MetHb) at 59.6% was successfully treated with HBO monotherapy. His MetHb levels significantly decreased from 59.6% to 34.0%, then 12.8%, 6.2%, and finally 3.5%, leading to discharge the next day.
What This Means for Canadian Patients
This case suggests that HBO monotherapy could be a viable alternative treatment for methemoglobinemia when methylene blue, the first-line therapy, is unavailable. Canadian patients suffering from methemoglobinemia might benefit from this treatment option in situations where standard therapy cannot be administered.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A key limitation of this study is that it is a single case report, which limits the generalizability of the findings.